Position in ALKS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$570,003
+$497,703 QoQ
Shares Held
16,120
+523.8% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
23 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ALKS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Tower Research Capital LLC (TRC) holds $6,300,576 across 59 Drug Manufacturers - Specialty & Generic names. ALKS ranks #2 (9.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
1,684 | $998,578 | |
| 2 | ALKS |
Alkermes plc.
This page
|
16,120 | $570,003 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
4,070 | $536,181 | |
| 4 | ELAN |
Elanco Animal Health Inc
|
19,404 | $464,337 | |
| 5 | LNTH |
Lantheus Holdings, Inc.
|
6,000 | $455,100 | |
| 6 | ZTS |
Zoetis Inc.
|
3,469 | $410,069 | |
| 7 | HIMS |
Hims & Hers Health, Inc.
|
16,717 | $347,044 | |
| 8 | BCRX |
Biocryst Pharmaceuticals Inc
|
23,887 | $227,404 |
All Filings in ALKS
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $570,003 | 16,120 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $72,300 | 2,584 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $133,920 | 4,464 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $392,242 | 13,710 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $240,153 | 7,273 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $594,583 | 20,674 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $117,277 | 4,190 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $589,100 | 24,444 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $10,150 | 375 | Shares | Other | 2024-05-15 | |
| 2023-12-31 | $1,126,521 | 40,610 | Shares | Other | 2024-02-13 | |
| 2023-09-30 | $74,197 | 2,649 | Shares | Other | 2023-11-14 | |
| 2023-06-30 | $233,873 | 7,472 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $143,684 | 5,097 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $53,513 | 2,048 | Shares | Other | 2023-02-10 | |
| 2022-09-30 | $439,364 | 19,676 | Shares | Other | 2022-11-10 | |
| 2022-06-30 | $376,723 | 12,646 | Shares | Other | 2022-08-15 | |
| 2022-03-31 | $34,176 | 1,299 | Shares | Other | 2022-05-12 | |
| 2021-12-31 | $378,113 | 16,256 | Shares | Other | 2022-02-14 | |
| 2021-09-30 | $194,569 | 6,309 | Shares | Other | 2021-11-15 | |
| 2021-06-30 | $164,185 | 6,696 | Shares | Other | 2021-08-16 | |
| 2021-03-31 | $25,853 | 1,384 | Shares | Other | 2021-05-17 | |
| 2020-12-31 | $429,324 | 21,520 | Shares | Defined | 2021-02-16 | |
| 2020-06-30 | $86,510 | 4,457 | Shares | Other | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||